Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;32(4):244-252.
doi: 10.1177/1742271X231226302. Epub 2024 Feb 14.

Evaluating the Role of Ultrasound in Prostate Cancer trial - phase 1: Early experience of micro-ultrasound in the United Kingdom

Affiliations

Evaluating the Role of Ultrasound in Prostate Cancer trial - phase 1: Early experience of micro-ultrasound in the United Kingdom

Pamela Parker et al. Ultrasound. 2024 Nov.

Abstract

Purpose: The purpose of this study was to evaluate if the use of micro-ultrasound can detect clinically significant prostate pathology when compared to histology obtained during a transperineal prostate biopsy.

Methods: Patients suspected of having prostate cancer, who had a pre-biopsy magnetic resonance imaging and could tolerate a transrectal examination, were prospectively recruited. All patients had a micro-ultrasound scan prior to their biopsy. The findings of magnetic resonance imaging, micro-ultrasound and histology were risk stratified in accordance with local pathways. Comparison of assigned risk scores was made using histology as the reference standard.

Results: Data from 101 patients were evaluated. Histology showed that clinically significant prostate cancer was detected in 48.5% (n = 49/101) of patients. Moderate inter-rater agreement was found in both magnetic resonance imaging and micro-ultrasound with К of 0.31 in both modalities. High-risk findings were identified in 81% (n = 82/101) patients at magnetic resonance imaging and in 66% (n = 67/101) patients at micro-ultrasound. Sensitivity and specificity of magnetic resonance imaging were found to be 87% and 34.6% and for micro-ultrasound 73.3% and 53.8%, respectively.

Conclusion: A limitation of this study was that the biopsy was not performed with micro-ultrasound which may have resulted in unidentified cancers and lowered the apparent accuracy of the technique. However, we conclude that while micro-ultrasound was diagnostic, magnetic resonance imaging demonstrated higher sensitivity in our local population and remains the pre-biopsy imaging modality of choice. However, the higher specificity of micro-ultrasound identified does indicate that it may be of value when magnetic resonance imaging is contraindicated. The role of micro-ultrasound, within an active surveillance pathway for prostate cancer, warrants further investigation.

Keywords: Sonographer; active surveillance; diagnosis; micro-ultrasound; prostate biopsy.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Similar articles

References

    1. Merriel SWD, Hetherington L, Seggie A, et al.. Best practice in active surveillance for men with prostate cancer: a prostate cancer UK consensus statement. BJU Int 2019; 124: 47–54. - PMC - PubMed
    1. Vasarainen H, Salman J, Salminen H, et al.. Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS). World J Urol 2015; 33: 1735–1740. - PubMed
    1. Bruinsma SM, Zhang L, Roobol MJ, et al.. The Movember Foundation’s GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date. BJU Int 2018; 121: 737–744. - PubMed
    1. Prostate Cancer UK, https://prostatecanceruk.org/ (2020, accessed 16 October 2023).
    1. Movember Foundation. Prostate cancer, https://uk.movember.com/about/prostate-cancer (2020, accessed 23 September 2022).

LinkOut - more resources